Product NDC: | 0009-0555 |
Proprietary Name: | Lincocin |
Non Proprietary Name: | LINCOMYCIN HYDROCHLORIDE |
Active Ingredient(s): | 300 mg/mL & nbsp; LINCOMYCIN HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-0555 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050317 |
Marketing Category: | NDA |
Start Marketing Date: | 19641229 |
Package NDC: | 0009-0555-02 |
Package Description: | 10 mL in 1 VIAL (0009-0555-02) |
NDC Code | 0009-0555-02 |
Proprietary Name | Lincocin |
Package Description | 10 mL in 1 VIAL (0009-0555-02) |
Product NDC | 0009-0555 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | LINCOMYCIN HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL |
Start Marketing Date | 19641229 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | LINCOMYCIN HYDROCHLORIDE |
Strength Number | 300 |
Strength Unit | mg/mL |
Pharmaceutical Classes |